829-13769-43458
3 vaccinations
3 coded responses
28 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 220 / VA
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-04
Survey response — day 0, dose 1MedDRA: Fatigue — Feeling: Good · Fever · Fatigue or tirednessFree text: Tired, but no fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-07-01
-
2021-08-23
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-04
- 2021-11-23
-
2022-02-23
Survey response — 6 months, dose 3MedDRA: Chills, Cough, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fever, chills, cough. Tested positive for COVID-19 on January 1, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-08-23
Survey response — 12 months, dose 3MedDRA: Emergency care, Hospitalisation, Sepsis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Hospitalized with a septic infection in April 2022 · Healthcare visit (other): ER and the. Admitted to hospital for care, including IV antibioticsMedDRA releases: 2024-11 · check-in free text available
-
2022-08-23
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-08-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-08-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Tired, but no fatigue
Release 11 — 6 months, dose 3
Symptoms: Fever, chills, cough. Tested positive for COVID-19 on January 1, 2022
Release 12 — 12 months, dose 3
Symptoms: Hospitalized with a septic infection in April 2022
Healthcare visit (other): ER and the. Admitted to hospital for care, including IV antibiotics
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | · | · | ✓ |
| HCVO | Hospitalisation | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sepsis | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release